These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 111085

  • 1. [Treatment of alcoholic toxic fatty liver. A placebo-controlled trial with hepavis (author's transl)].
    Deynet G, Reimer F.
    MMW Munch Med Wochenschr; 1979 Jun 15; 121(24):831-2. PubMed ID: 111085
    [Abstract] [Full Text] [Related]

  • 2. [Does Hepavis have value in the therapy of fatty liver caused by alcohol poisoning?].
    Odegaard S, Busch D.
    Z Gastroenterol; 1989 Feb 15; 27(2):91-3. PubMed ID: 2658394
    [Abstract] [Full Text] [Related]

  • 3. [Reflections on medicamentous liver-therapy. Hepavis in medical practice].
    Wegener W.
    Med Monatsschr; 1977 Jul 15; 31(7):328-30. PubMed ID: 904570
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Active therapeutic exercises in combination with vasoactive drug in intermittent claudication (author's transl)].
    Krause D, Dittmar K.
    MMW Munch Med Wochenschr; 1978 Jan 20; 120(2-3):69-72. PubMed ID: 414129
    [Abstract] [Full Text] [Related]

  • 11. [Therapeutic progress in chronic liver diseases].
    Wildhirt E.
    Dtsch Z Verdau Stoffwechselkr; 1968 Jan 20; 28(2):207-8. PubMed ID: 4894834
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Alcoholic liver diseases and their treatment].
    Cacciatore L, Antoniello S, Russo M.
    Clin Ter; 1989 Nov 30; 131(4):225-32. PubMed ID: 2480864
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of alcoholic liver diseases. Abstinence, nutritional support, drug therapy, liver transplantation].
    Pár A.
    Orv Hetil; 2000 Apr 16; 141(16):827-33. PubMed ID: 10817009
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS, Dzhalalov KD, Blok IuE, Bendikov EA, Ausheva LKh.
    Ter Arkh; 1986 Apr 16; 58(2):73-6. PubMed ID: 3704945
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B, Schwarz M, Domke I, Grunert VP, Wuertemberger M, Schiemann U, Horster S, Limmer C, Stecker G, Soyka M.
    Addiction; 2005 Oct 16; 100(10):1477-86. PubMed ID: 16185209
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of cirrhosis of the liver by a combination of Lipovitan and orotic acid (author's transl)].
    Fassati P, Spízek J, Fassati M.
    Cas Lek Cesk; 1980 Jul 11; 119(27-28):770-3. PubMed ID: 7428000
    [No Abstract] [Full Text] [Related]

  • 20. Inhibitory effect of osthole on alcohol-induced fatty liver in mice.
    Sun F, Xie ML, Zhu LJ, Xue J, Gu ZL.
    Dig Liver Dis; 2009 Feb 11; 41(2):127-33. PubMed ID: 18339590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.